NaviFUS Corp. (TPEX:6872)

Market Cap	1.54B +8.5%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	70.74M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,404
Open	23.40
Previous Close	22.05
Day's Range	21.65 - 23.40
52-Week Range	13.80 - 27.05
Beta	0.23
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About NaviFUS

NaviFUS Corp., a medical device company, develops and sells focused ultrasound (FUS) solutions for the unmet needs in neuromedicine in Taiwan. The company develops NaviFUS, a neuronavigator-guided transcranial FUS system that delivers focal energy into deep tissues in the brain, as well as is used in various clinical applications, such as drug delivery, neuromodulation, immuno-stimulation, and others. It also develops NAVIRFA, a navigation system that uses optical 3D surgical tracking technology to monitor the 3D position of the needle tip duri...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2015
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6872

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 8, 2026

Data Sources Report a data error